Navigation Links
High Intensity Focused Ultrasound Physician Training Seminar in Mexico City

Leading HIFU device in Mexico for Minimally Invasive Treatment for Prostate Cancer and Benign Prostatic Hyperplasia draws attention from elite urologists

CHARLOTTE, N.C., March 16 /PRNewswire/ -- Mexico HIFU in conjunction with International HIFU, the Mexican and international entities of USHIFU, a global leader in the development, manufacturing and distribution of high intensity focused ultrasound (HIFU) technologies, will host the very first multiday Sonablate(R) HIFU physician training seminar in Mexico City, March 17-18, 2009 at Hospital Star Medica Santa Fe.

The two day training seminar using the Sonablate(R) HIFU device will host top urologists from several of Mexico's leading hospitals, including the Angeles Hospital Group, Clinical Lomas Altas and Hospital Star Medica. The training seminar will include an academic presentation which will provide an overview of the physics and science of HIFU as a therapy for prostate cancer and also discuss patient selection. Additionally, the seminar will incorporate a comprehensive review of international clinical outcomes and advanced one-on-one simulator training. The highlight for physicians attending the seminar will be observation and participation in live Sonablate(R) HIFU cases.

"There has been significant interest from the urology community within Mexico to bring this technology to Mexico's largest city. Within two days of announcing the training seminar, the limited number of spots were filled and we now have a waiting list of doctors from Guadalajara and Monterrey for the next HIFU physician training seminar," said Alex Gonzalez, Vice President of International Operations, USHIFU. "We are ecstatic to be working with such high caliber physicians and continue to spread awareness about HIFU for prostate cancer throughout Mexico."

Although this is the first training program of its kind in Mexico City, in the past four years, over 1000 patients have been treated in Mexico with minimally invasive Sonablate(R) HIFU in Guadalajara, Monterrey, Mexico City, Puerto Vallarta and Cancun.

About the Sonablate(R) 500

The Sonablate(R) 500 is a minimally invasive medical device that utilizes ultrasound energy to destroy tissue within the body. It was developed by FSI and is manufactured by Misonix, Inc. (Nasdaq: MSON) who also holds distribution rights in Europe. Takai Hospital Supply Ltd. and THS International distribute the Sonablate(R) 500 in Southeast Asia and the Middle East.

The Sonablate(R) 500 is not approved for use in the U.S. The Sonablate(R) 500 remains investigational in the U.S. and is being studied for the treatment of prostate cancer in clinical trials in the U.S. FDA has made no decision as to the safety or efficacy of the Sonablate(R) 500 for the treatment of prostate cancer.

About Mexico HIFU & International HIFU

Mexico HIFU is affiliated with USHIFU and International HIFU, the entity through which USHIFU conducts its international business operations and makes the HIFU technologies available to patients at centers outside the United States.


USHIFU is a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound technologies.

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Supports Intensity Scale is effective for identifying needs in people with intellectual disability
2. The Supports Intensity Scale Assessment Can be Used to Build Robust Funding Methods for Developmental Disability Services, New Research Reveals
3. Low-intensity case management cuts COPD-related hospital visits in half
4. High-intensity chemotherapy does not improve survival in small cell lung cancer
5. Low-intensity exercise reduces fatigue symptoms by 65 percent, study finds
6. Esphera3 International Founded on Patient Focused Care
7. Frost & Sullivan Recognizes Strategic Healthcare Programs for Best Practices in Focused Innovation
8. Fertility Focused Acupuncture NW & Associates to Open Clinic in Tacoma
9. Carefx Reports 200% Year-Over-Year Revenue Growth in 2008 as Demand Grows for Solutions Focused on Clinical Decision Making
10. NQFs Corrigan Tells Senate Committee That Investing in Health IT Holds Great Promise If It is Focused on Wringing Out Efficiencies and Coordinating Patient Care
11. WeissComm Group Acquires Strategic Branding Firm ODA and Enters Alliance With Patient-Focused Health Advocacy Strategies to Diversify Business and Expand Offerings
Post Your Comments:
(Date:11/28/2015)... ... November 28, 2015 , ... Pixel Film Studios is back ... to choose from, the possibilities are endless. Users have full control over angle of ... Pulse masking effects, users are sure to get heads to turn. , ProPanel: Pulse ...
(Date:11/27/2015)... ... , ... According to an article published November 15th by ABC ... security in light of the recent terrorist attacks in Paris, other cities are taking ... attack from reaching U.S. soil. Especially around special events that may be high-profile in ...
(Date:11/27/2015)... ... 27, 2015 , ... "When I was traveling, I was ... N.J. "Many people catch diseases simply from sitting on such dirty toilet seats. ... from germs." , He developed the patent-pending QUDRATECS to eliminate the need to ...
(Date:11/27/2015)... ... 27, 2015 , ... MPWH, the No.1 Herpes-only dating community in the world, revealed that over ... More than 3.7 billion people under the age of 50 – or 67% of ... WHO's first global estimates of HSV-1 infection . , "The data shocks us highly!" ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... ... failing. Secura Consultants has prided itself for not only fulfilling the needs of ... protection solutions at an affordable price and providing top-tier customer service. However, there's ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , Nov. 25, 2015 ... the addition of the "Global Brain ... their offering. --> ) ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( ) has ...
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: ... License Application (BLA) with the United States ... ABP 501, a biosimilar candidate to Humira ® ... biosimilar application submitted to the FDA and represents Amgen,s ... Sean E. Harper , M.D., executive vice president ...
(Date:11/25/2015)... 2015  Linden Care, LLC, a retail specialty pharmacy ... patients suffering from chronic pain, said today that it ... Order (TRO) enjoining Express Scripts from unilaterally terminating the ... --> --> The company said ... options. --> --> ...
Breaking Medicine Technology: